Group Therapy Versus Individual Therapy for Tourette Syndrome and Chronic Tic Disorder
1 other identifier
interventional
59
0 countries
N/A
Brief Summary
Chronic tic disorder (CTD) may have a huge impact on life quality. Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) are effective therapeutic modalities. This study examined the effect of a combined treatment using both HRT and ERP in children and adolescents with CTD. The treatment outcome was examined as an individual treatment compared to a group setting. There was no control group. The study examined both acute outcome and outcome at one year of follow-up. Predictive factors for treatment outcome were evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFirst Submitted
Initial submission to the registry
October 13, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedJuly 21, 2021
October 1, 2020
2.2 years
October 13, 2020
July 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of baseline Yale Global Tic Severity Scale (YGTSS) at 16 weeks, 24 weeks, 40 weeks and 68 weeks
Measures the change in Total tic score and functional impairment at different end points on the Yale Global Tic Severity Scale (unabbreviated scale title). Interval 0-100, high score means a worse outcome
Baseline,16 weeks, 24 weeks, 40 weeks, 68 weeks
Secondary Outcomes (2)
Change of baseline Premonitory urge (PUTS) at 6 weeks, 16 weeks, 24 weeks, and 68 weeks
Baseline, 6 weeks, 16 weeks, 24 weeks, 68 weeks
Change of baseline Beliefs About Tics Scale (BATS) at 6 weeks, 16 weeks, 24 weeks, and 68 weeks
Baseline, 6 weeks, 16 weeks, 24 weeks, 68 weeks
Study Arms (2)
Individual HRT and ERP
EXPERIMENTALIndividual treatment with habit reversal training (HRT) and exposure response prevention (ERP) according to a protocol
Group HRT and ERP
EXPERIMENTALGroup treatment with habit reversal training (HRT) and exposure response prevention (ERP) according to a protocol
Interventions
In an open randomized controlled study, youth were randomized to either individualized, or group treatment. Both therapies included nine sessions, and the parents were offered one group-session.
Eligibility Criteria
You may qualify if:
- A primary diagnosis of either Tourette syndrome or a chronic motor/vocal tics disorder
- Moderate or greater severity corresponding to a total score on the Yale Global Tic Severity Scale (YGTSS) higher than 13 (higher than nine if only motor or vocal tics were described)
You may not qualify if:
- Disorders that required immediate treatment
- psychotic disorder
- primary severe depression
- suicidal ideation or attempts
- primary severe anorexia nervosa
- Disorders that makes participation difficult
- IQ below 70
- a life-time diagnosis of pervasive developmental disorder
- Treatment with HRT or ERP during the last six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Nissen JB, Carlsen AH, Thomsen PH. One-year outcome of manualised behavior therapy of chronic tic disorders in children and adolescents. Child Adolesc Psychiatry Ment Health. 2021 Feb 20;15(1):9. doi: 10.1186/s13034-021-00362-w.
PMID: 33610169DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith Nissen
Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Evaluations of treatment response were made by an independent evaluator who was not blinded to the treatment allocation, yet not involved in the treatment of the patient, and blinded to any previous evaluations. The evaluators were a specialized psychologist and a child and adolescent psychiatrist with several years of experience in diagnosing, evaluating and treating tic disorders. A random sample of 10% were audiotaped and evaluated by another rater with extensive experience and expertise in the use of the YGTSS
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, senior researcher
Study Record Dates
First Submitted
October 13, 2020
First Posted
October 20, 2020
Study Start
November 1, 2015
Primary Completion
December 31, 2017
Study Completion
December 31, 2018
Last Updated
July 21, 2021
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share
In accordance to Danish law, personal data cannot be shared